| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.1 |